Madrigal Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $380,496,000.
Profit Margin
| 2014 | 0 | -86.16M | |
|---|---|---|---|
| 2015 | 0 | -68.67M | |
| 2016 | 0 | -26.38M | |
| 2017 | 0 | -31.15M | |
| 2018 | 0 | -32.81M | |
| 2019 | 0 | -72.81M | |
| 2020 | 0 | -197.44M | |
| 2021 | 0 | -241.07M | |
| 2022 | 0 | -299.31M | |
| 2023 | 0 | -373.63M |
MDGL Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 527K | 467K | 405K | 471K | 112K | 0 | 77K | 0 | 0 | 0 |
Gross profit | -527K | -467K | -405K | -471K | -112K | 0 | -77K | 0 | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 272.35M | 245.44M | 205.16M | 184.80M | 72.32M | 25.38M | 24.39M | 15.93M | 54.21M | 68.20M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 380.49M | 293.57M | 242.48M | 206.67M | 94.97M | 40.68M | 32.06M | 25.22M | 67.61M | 83.95M |
Operating income | -380.49M | -293.57M | -242.48M | -206.67M | -94.97M | -40.68M | -32.06M | -25.22M | -67.61M | -83.95M |
Other income (expenses), net | 6.86M | -1.77M | 636K | 4.42M | 11.02M | 200K | 908K | -1.16M | 60.76M | -2.21M |
Income before tax | -373.63M | -295.35M | -241.84M | -202.24M | -83.94M | -32.81M | -31.15M | -26.38M | -68.67M | -86.16M |
Income tax expense | 0 | 3.96M | -768K | -4.8M | -11.13M | 7.87M | -635K | -373 | 0 | 0 |
Net income | -373.63M | -299.31M | -241.07M | -197.44M | -72.81M | -32.81M | -31.15M | -26.38M | -68.67M | -86.16M |
Earnings per share | ||||||||||
Basic EPS | -19.99 | -17.47 | -14.58 | -12.78 | -4.73 | -2.22 | -2.54 | -5.07 | -401.56 | -30.62 |
Diluted EPS | -19.99 | -17.47 | -14.58 | -12.78 | -4.73 | -2.22 | -2.54 | -5.07 | -401.56 | -30.62 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |